Compressing vaccine development timelines to 100 days will require a step-change in how we manufacture vaccines.
Dedicated global surveillance of high-risk pathogens can speed identification of Disease X, which will be crucial to achieving the 100 days mission.
The world can face down the next Disease X with a new vaccine in just 100 days. Here’s how…
Development of rapid-response vaccine technology will be crucial in enabling the world to achieve the 100 days mission.
Creation of vaccine libraries will help the world develop vaccines against the next Disease X in 100 days.
Causing rapidly progressive illness, including inflammation of the brain, Nipah virus is one of the deadliest pathogens known to infect humans. We must advance research and develop tools to protect against this disease.
Partnerships with MigVax Ltd and University of Saskatchewan's Vaccine & Infectious Disease Organization kick off programme to develop broadly protective vaccines against COVID-19 variants and other coronaviruses.
